Literature DB >> 7675209

Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat.

P Barnéoud1, S Parmentier, M Mazadier, J M Miquet, A Boireau, P Dubédat, J C Blanchard.   

Abstract

This study compares certain behavioural consequences of partial and complete unilateral lesions of the dopaminergic mesotelencephalic system. We investigated skilled forelimb use, rotations induced by apomorphine and amphetamine, and dopaminergic metabolism of the nigrostriatal system of rats that had received a unilateral injection of 6-hydroxydopamine into the medial forebrain bundle. The rats classified Apo(+), that rotated after the administration of apomorphine, had a complete lesion of the nigrostriatal system, whereas those classified Apo(-), that did not rotate after the administration of apomorphine, had a partial lesion of the nigrostriatal system. In the Apo(+) rats, 99.8% of the dopamine in the striatum was depleted, as was 85% of that in the substantia nigra. For the Apo(-) rats, 72% of the dopamine in the striatum was depleted as was 56% of that in the substantia nigra. When investigated with the staircase test, the animals with the most severe dopamine depletions were those most impaired in the paw reaching task. Complete and partial unilateral depletions of the dopaminergic mesotelencephalic system impaired the hierarchic phases of paw reaching differently. A complete dopamine depletion, but not a partial one, decreased the number of attempts made with the contralateral paw, and induced a bias towards the ipsilateral paw. A partial dopamine lesion impaired the sensorimotor co-ordination of both paws, whereas the complete dopamine lesion had a greater effect on the contralateral paw than on the ipsilateral paw. The mild paw reaching impairments observed in animals with moderate depletions of dopamine are proposed as a model of the early symptoms of Parkinson's disease that may be useful for the development of protective or restorative therapies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675209     DOI: 10.1016/0306-4522(95)00112-v

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Role of nitric oxide on motor behavior.

Authors:  E A Del Bel; F S Guimarães; M Bermúdez-Echeverry; M Z Gomes; A Schiaveto-de-souza; F E Padovan-Neto; V Tumas; A P Barion-Cavalcanti; M Lazzarini; L P Nucci-da-Silva; D de Paula-Souza
Journal:  Cell Mol Neurobiol       Date:  2005-03       Impact factor: 5.046

2.  Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion.

Authors:  N R Ferreira; M Mitkovski; W Stühmer; L A Pardo; E A Del Bel
Journal:  Neurotox Res       Date:  2011-11-03       Impact factor: 3.911

3.  Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

Authors:  P Akerud; J M Canals; E Y Snyder; E Arenas
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 4.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Change of Extracellular Glutamate Level in Striatum during Deep Brain Stimulation of the Entopeduncular Nucleus in Rats.

Authors:  Hyun-Ju Lee; Jae Hoon Sung; Jae Taek Hong; Il Sup Kim; Seung Ho Yang; Chul Bum Cho
Journal:  J Korean Neurosurg Soc       Date:  2019-02-27

Review 6.  Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective.

Authors:  Rajashree Banerjee; Arushi Rai; Shreyas M Iyer; Sonia Narwal; Meghana Tare
Journal:  Animal Model Exp Med       Date:  2022-01-27

7.  Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson's Disease.

Authors:  Anja Pišlar; Larisa Tratnjek; Gordana Glavan; Marko Živin; Janko Kos
Journal:  Front Mol Neurosci       Date:  2018-11-02       Impact factor: 5.639

Review 8.  Rat Models of Vocal Deficits in Parkinson's Disease.

Authors:  Maryann N Krasko; Jesse D Hoffmeister; Nicole E Schaen-Heacock; Jacob M Welsch; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  Brain Sci       Date:  2021-07-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.